The Ministry of Health and Family welfare vide its notification dated 7th April 2021 has published the the Drugs (3rd Amendment) Rules, 2021 which shall come into force from 1st November 2021
The Amendment brings in Tapentadol, a synthetic opioid analgesic under Schedule H1 to regulate its sale, distribution and prevent its abuse and Schedule H1 stipulates that the drug can be sold only on prescription.
Healthcare providers may continue to safely use the products listed above if the fibrin sealant is prepared in advance to ensure it is fully dissolved
The Indian Nursing Council (INC) has issued a reminder to medical institutions that have not yet received suitability renewal for the academic year 2024-25. The
The Post Graduate Medical Education Board (PGMEB) of the National Medical Commission (NMC) has withdrawn its previous notice regarding the discontinuation of courses offered by
The CBME guidelines, developed in collaboration with expert groups, aim to transform medical education in India by focusing on developing essential competencies in medical graduates.
Stay up-to-date with the latest regulatory developments from Legality Alerts, directly in your inbox. Never miss another important regulatory compliance news alert.
Solutions
Resources
